Concepedia

Brian E. Cathers

BE

Statistics

Publications

32

Citations

5.5K

H-Index

23

Active since

1997

Affiliations

Bristol-Myers Squibb (Switzerland)(Current)

Bristol-Myers Squibb (United States)

University of California San Diego

Tokyo Medical University

La Jolla Bioengineering Institute

Brian E. Cathers is an author at Bristol-Myers Squibb (Switzerland) specializing in molecular oncology, pharmacology, and medicine.

ORCID

Publications per year

1997–2023

32

Publications

32

Lenalidomide induces ubiquitination and degradation of CK1α in del(5q) MDS

Jan Krönke, Emma C. Fink, Paul W. Hollenbach et al. · Nature · 2015 · 836 citations · Full text

, , +8

Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide

Antonia Lopez‐Girona, Derek Mendy, Takumi Ito et al. · Leukemia · 2012 · 798 citations · Full text

, , +15

Inhibition of Human Telomerase by a G-Quadruplex-Interactive Compound

Daekyu Sun, Brian Thompson, Brian E. Cathers et al. · Journal of Medicinal Chemistry · 1997 · 784 citations · Full text

, , +11

A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase

Mary E. Matyskiela, Gang Lu, Takumi Ito et al. · Nature · 2016 · 670 citations

, , +11

Structure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogs

Philip P. Chamberlain, Antonia Lopez‐Girona, Karen Miller et al. · Nature Structural & Molecular Biology · 2014 · 515 citations

, , +5

1–5 of 32